ACTIVITY OF CYTOSTATIC DRUGS IN 2 HETEROTRANSPLANTED HUMAN TESTICULAR CANCER CELL-LINES WITH DIFFERENT SENSITIVITY TO STANDARD AGENTS

被引:11
|
作者
HARSTRICK, A
SCHMOLL, HJ
CASPER, J
WILKE, H
POLIWODA, H
机构
[1] Department of Hematology and Oncology, University of Hannover Medical School, 3000 Hannover 61
关键词
D O I
10.1016/0277-5379(90)90195-Y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Two established human testicular cancer cell lines were used in a mouse xenograft model to assess the antitumour activity of 15 anticancer agents. Line H 12.1 was highly sensitive to cisplatin, bleomycin and vinblastine, resembling non-pretreated testicular tumours, whereas line H 23.1 showed resistance to cisplatin and vinblastine, comparable to tumours with acquired or intrinsic drug resistance. In line H 12.1 several drugs were highly active, including cyclophosphamide, ifosfamide, nimustine and vincristine; carmustine, vindesine, doxorubicin, epidoxorubicin, pirarubicin, mitoxantrone, carboplatin and iproplatin had only moderate activity. In line H 23.1 only cyclophosphamide, ifosfamide, nimustine, vincristine and bleomycin had antitumour activity. These two cell lines represent a useful model for preclinical evaluation of new agents with presumed activity in testis cancer. © 1990.
引用
收藏
页码:898 / 901
页数:4
相关论文
共 50 条
  • [1] MODULATION OF CYTOSTATIC DRUGS BY NIFEDIPINE IN 2 HETEROTRANSPLANTED HUMAN TESTICULAR-CANCER CELL-LINES DIFFERING IN THEIR SENSITIVITY TO STANDARD AGENTS
    BOKEMEYER, C
    DUNN, T
    HARSTRICK, A
    LERCH, T
    POLIWODA, H
    SCHMOLL, HJ
    INTERNATIONAL JOURNAL OF CANCER, 1994, 56 (03) : 452 - 456
  • [2] CYTOSTATIC TREATMENT OF HETEROTRANSPLANTED HUMAN HODGKIN CELL-LINES IN NUDE-MICE
    KIRCHNER, HH
    GRONAU, HO
    DIEHL, V
    POLIWODA, H
    BLUT, 1987, 55 (04): : 347 - 347
  • [3] THE ANTITUMOR-ACTIVITY OF IFOSFAMIDE ON HETEROTRANSPLANTED TESTICULAR CANCER CELL-LINES REMAINS UNALTERED BY THE UROPROTECTOR MESNA
    BOKEMEYER, C
    SCHMOLL, HJ
    LUDWIG, E
    HARSTRICK, A
    DUNN, T
    CASPER, J
    BRITISH JOURNAL OF CANCER, 1994, 69 (05) : 863 - 867
  • [4] ANTITUMOR-ACTIVITY AND TOXICITY OF CONTINUOUS-INFUSION VERSUS BOLUS ADMINISTRATION OF BLEOMYCIN IN 2 HETEROTRANSPLANTED HUMAN TESTICULAR CANCER CELL-LINES
    BOKEMEYER, C
    LUDWIG, E
    REILE, D
    HARSTRICK, A
    POLIWODA, H
    SCHMOLL, HJ
    ONCOLOGY REPORTS, 1995, 2 (01) : 161 - 165
  • [5] DIFFERENTIAL SENSITIVITY OF HUMAN CELL-LINES TO ANTI-CANCER DRUGS
    LAZARUS, H
    MALONE, B
    WADE, K
    BARELL, E
    IN VITRO-JOURNAL OF THE TISSUE CULTURE ASSOCIATION, 1979, 15 (03): : 176 - 176
  • [6] EFFECTS OF POLYAMINE DEPLETION ON THE SUSCEPTIBILITY OF HUMAN RENAL AND PROSTATE-CANCER CELL-LINES TO CYTOSTATIC AGENTS
    ROMIJN, JC
    VERKOELEN, CF
    KURTH, KH
    SPLINTER, TAW
    JOURNAL OF UROLOGY, 1987, 137 (04): : A253 - A253
  • [7] RADIATION SENSITIVITY OF HUMAN-LUNG CANCER CELL-LINES
    CARMICHAEL, J
    DEGRAFF, WG
    GAMSON, J
    RUSSO, D
    GAZDAR, AF
    LEVITT, ML
    MINNA, JD
    MITCHELL, JB
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1989, 25 (03): : 527 - 534
  • [8] MUSCARINIC RECEPTOR SENSITIVITY IN 2 HUMAN NEUROBLASTOMA CELL-LINES WITH DIFFERENT ACTIVATED ONCOGENES
    HEIKKILA, J
    JALAVA, A
    AKERMAN, K
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1987, 23 (11): : 1759 - 1759
  • [9] DIFFERENTIAL SENSITIVITIES OF HUMAN TESTICULAR AND BLADDER-TUMOR CELL-LINES TO CHEMOTHERAPEUTIC DRUGS
    WALKER, MC
    PARRIS, CN
    MASTERS, JRW
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1987, 79 (02) : 213 - 216
  • [10] CYTOSTATIC ACTIVITY OF INVITRO ACTIVATED HUMAN ADHERENT CELLS AGAINST HUMAN-TUMOR CELL-LINES
    MATSUNAGA, K
    MASHIBA, H
    GOJOBORI, M
    GANN, 1980, 71 (01): : 73 - 79